News of Note—GlaxoSmithKline, Ebola and SK Bioscience

In this week's news of note, the World Health Organization declared an end to the Ebola outbreak in Congo. (Pixabay)

Here is some other vaccine news of note for the week.

> GlaxoSmithKline has reported £1.25 billion ($1.65 billion) in second-quarter vaccine sales, a 16% increase at constant currencies. Reuters story

> The World Health Organization has declared an end to the Ebola outbreak in the Democratic Republic of Congo. Release

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

> South Korea's SK Bioscience is spending $89 million on a plant to increase vaccine capacity. Pulse story